Tenosynovitis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for tenosynovitis. 73 active patents protecting 5 drugs from 3+ originators. First major cliff: 2032. Daily refresh.

5
Approved drugs
73
Active US patents
59/100
Avg vulnerability
—
Annual revenue covered

Originators in Tenosynovitis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Merck/Upjohn) 29 patents Pfizer 24 patents Hisamitsu Pharmaceutical Co., Inc 14 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating tenosynovitis. Each bar = one year. Y-axis scaled to peak year (24 patents).

14
27
2
28
9
29
24
30
5
32
4
33
7
34
1
36
3
37
1
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Arthrotec
Diclofenac Sodium
 Pfizer 24 73 — 2027-03-22
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Voltaren
DICLOFENAC
 Hisamitsu Pharmaceutical Co., Inc 14 57 — 2030-04-23
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Indocin Sr
INDOMETHACIN
 — 6 56 — 2030-04-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8946292 Arthrotec method of use 80 2027-03-22
8871809 Arthrotec method of use 80 2027-10-17
8563613 Arthrotec method of use 80 2027-10-17
8252838 Arthrotec method of use 80 2028-04-21
9539335 Arthrotec method of use 75 2027-10-17
9132110 Arthrotec method of use 75 2027-10-17
9220784 Arthrotec method of use 75 2027-10-17
9339551 Arthrotec method of use 75 2027-10-17
9168305 Arthrotec method of use 75 2027-10-17
9101591 Arthrotec method of use 75 2027-10-17

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
8450287 Decadron formulation 38 2027-12-19
10022502 Decadron method of use 45 2034-06-22
10028965 Decadron method of use 45 2034-05-23
9017721 Voltaren formulation 48 2030-04-23
9173854 Voltaren formulation 48 2030-04-23
9180096 Voltaren formulation 48 2030-04-23

Related